ITRM (Iterum Therapeutics, plc) Earnings per share growth rate in current year

Official company branding of iterumtx.com (ITRM)

Iterum Therapeutics plc (ITRM) minimizes operational risks by outsourcing drug production to external CDMO centers. This annual EPS growth chart provided by GURU.Markets demonstrates a recovery trend, with the metric holding around 0.00. The business model relies on the high margins of proprietary antibiotics, while development is conducted within Western legal frameworks, ensuring full protection from geopolitical sanctions.

iterumtx.com (ITRM): Net earnings per share growth this year from 07/04/2022 to 04/11/2026

Analytical breakdowns and data insights for company iterumtx.com (ITRM)

- current price and projected stock value:
Quote Chart Iterum Therapeutics PLC|ITRM - Analyst Consensus Forecast
- business market valuation indicators:
Market Value Iterum Therapeutics|ITRM - Enterprise Value
- balance sheet equity data:
Accounting Value per Share Iterum Therapeutics|ITRM - Company Net Assets|Market Cap to Book Value Multiple iterumtx.com|ITRM - Company Total Assets
- debt burden and liquidity indicators:
Total Debt to Capital Coefficient Iterum Therapeutics plc|ITRM - Long-Term Debt to Equity|Current Liabilities to Capital Iterum Therapeutics, plc|ITRM - Company Debts|Debt to Book Value Ratio Iterum Therapeutics plc|ITRM - Company Long-Term Debt|Short-Term Debt Volume Iterum Therapeutics|Interim Coverage Ratio iterumtx.com
- net income and valuation ratios data:
ITRM - Net Income|Future Net Profit Iterum Therapeutics plc|ITRM - P/E Multiple|Projected Price to Earnings Ratio Iterum Therapeutics, plc|ITRM - Price/Earnings to Growth Ratio|Business Value to Operating Income Before Depreciation Iterum Therapeutics PLC|ITRM - Operating profit before deduction of amortization|Net earnings per share (EPS TTM) Iterum Therapeutics|ITRM - Earnings per share for the last twelve months|Year-over-year net earnings per share growth for the last 12 months iterumtx.com|ITRM - Net earnings per share growth this year|Expected earnings per share trend next year Iterum Therapeutics plc
- company sales and revenue statistics:
ITRM - Company Sales|Company Projected Revenue Volume Iterum Therapeutics PLC|ITRM - P/S Multiple|Forward Price to Sales Iterum Therapeutics|ITRM - Sales Growth YoY (TTM)
Basic company analysis:iterumtx.com
Mass-produced product of Iterum Therapeutics plc

Earnings per share dynamics determine the annual growth rate of the business's net yield. This comparison of annual EPS growth measures profit generation efficiency relative to previous periods. While a positive trend confirms capital scaling, sharp peaks often mask the risk of future drawdowns. For Iterum Therapeutics plc (ITRM), this indicator is critical due to its dependence on a single drug. The binary risk of a regulatory decision makes current earnings volatility a determining factor for the company's survival.

Main competitors

Earnings per share trend in current year SMMT (Summit Therapeutics Inc)|MRNA (Moderna Inc) - Earnings growth in current year|Earnings per share growth rate in current year Vaxcyte, Inc. PCVX|Earnings growth in current year TARS|Net earnings per share growth this year CorMedix Corp CRMD|Seres Therapeutics, Inc. - Net earnings per share growth this year|Net earnings per one share growth for the current year SPRO (Spero)|SCYNEXIS Inc - Earnings growth in current year|Expected net earnings per share growth this year AN2 Therapeutics ANTX|polypid.com (PYPD) - Earnings per share growth in current year|Earnings per share growth this year LSB|Earnings per share growth in current year BiomX|Earnings per share growth this year SNGX (soligenix.com)|Earnings per share growth in current year 60 Degrees Pharma (SXTP)|Expected net earnings per share growth this year Oragenics Inc.|Earnings per share growth in current year OpGen Corporation OPGN